Cost-Effectiveness of IncobotulinumtoxinA in the Treatment of Sialorrhea in Patients with Various Neurological Conditions
Crossref DOI link: https://doi.org/10.1007/s40120-020-00182-8
Published Online: 2020-03-12
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Makino, Koji
Mahant, Neil
Tilden, Dominic
Aghajanian, Lara
Funding for this research was provided by:
Merz Pharmaceuticals
Text and Data Mining valid from 2020-03-12
Version of Record valid from 2020-03-12
Article History
Received: 8 November 2019
First Online: 12 March 2020